Trimming This Small-Cap Biotech on Strength as We Eye the Chart
Here’s what we’re seeing technically ahead of next week’s earnings.
Here’s what we’re seeing technically ahead of next week’s earnings.
Plus, Wall Street is taking a new look at SoFi.
The financial services firm appears to be cooking with gas.
We’re sticking with this price target as the chart suggests. a good time to initiate or add.
As Rocket Labs teases, I’m buying more, but lowering my expectations.
We’re moving price targets on three small-cap names amid technical developments.
We’re looking to increase four positions of the small-cap portfolio.
Our repair work continues on the $10,000 Portfolio.
Four buys, one sale and one exit as we fight back and right the ship.